Russian lawmaker comments on US decision to end military subsidies to UkraineRussian Politics & Diplomacy May 24, 16:30
Nine Russian missile regiments rearmed with advanced ICBM systemsMilitary & Defense May 24, 16:01
Perm session completes cycle of regional offsite events in run-up to SPIEF 2017Press Releases May 24, 15:38
Ka-52 helicopters to have advanced weapon targeting systemMilitary & Defense May 24, 15:09
Amsterdam Court may look into appeal against Scythian Gold ruling in fallSociety & Culture May 24, 15:04
Russian ground forces to be fully rearmed with Iskander-M ballistic missiles by late 2020Military & Defense May 24, 14:58
Russian security chief calls for cooperation on cyber threatsRussian Politics & Diplomacy May 24, 14:34
About half of Russian Navy warships to be armed with Kalibr cruise missiles by late 2020Military & Defense May 24, 14:31
Stalin’s grandson passes away at 75Society & Culture May 24, 14:26
MOSCOW, May 27. /TASS/. Doping test result of Russian heavyweight boxer Alexander Povetkin, who Sample B tested positive for banned substance meldonium, was not unexpected news and his team was ready for it, Andrei Ryabinsky, the head of the Boxing World promotion company told TASS on Friday.
"It was expected," Ryabinsky said in an interview with TASS. "We never denied that it [meldonium] was there [in Povetkin’s blood]."
WBC Heavyweight Champion Deontay Wilder of the United States (W36-L0, 35 KOs) was scheduled to hold his mandatory title bout against Povetkin (30-1, 22 KOs) on May 21 in Moscow, However, Russian boxer’s doping Sample A had tested positive for meldonium shortly before the fight and the bout was suspended indefinitely.
"This story is about the low concentration of detected meldonium," Ryabinsky said. "However, nobody ever denied that it was present in the [doping] samples."
The found drug in the body system of the 36-year-old Russian fighter was in low concentration of 0.07 micrograms. US sports channel ESPN later reported that before the positive doping result, Povetkin passed doping tests three times, namely on April, 7,8 and 11, and all his samples tested negative. However, his doping test as of April 27 gave a positive indication for meldonium presence in his blood.
Wilder’s management announced earlier it intended to demand from the Russian side a financial compensation of $4.6 million in case the bout was eventually cancelled.
The drug meldonium (mildronate) was included in the list of preparations banned by WADA from January 1, 2016. The presence of the meldonium substance in the athlete’s blood during and between competitions is a violation of anti-doping rules. The substance belongs to S4 class on the WADA blacklist (hormones and metabolic modulators).
However, on April 13, WADA announced that the concentration of less than one microgram of meldonium in the body system of an athlete, whose doping tests were conducted before March 1, was acceptable.
Meldronate is a cardiovascular preparation freely available for purchase at pharmacies across Russia without doctor’s prescription.